Access the full text.
Sign up today, get DeepDyve free for 14 days.
CR Antonescu (1997)
10.1097/00000478-199711000-00003Am J Surg Pathol, 21
S Domcke (2013)
10.1038/ncomms3126Nat Commun, 4
M Ikram (2003)
10.1177/014556130308200618Ear Nose Throat J, 82
MA Adelani, SJ Schultenover, GE Holt, JM Cates (2009)
Primary leiomyosarcoma of extragnathic bone: clinicopathologic features and reevaluation of prognosisArch Pathol Lab Med, 133
JR Wisniewski, A Zougman, N Nagaraj, M Mann (2009)
Universal sample preparation method for proteome analysisNat Methods, 6
MM Tomayko (1989)
10.1007/BF00300234Cancer Chemother Pharmacol, 24
JA Ursick, FH Linthicum (2011)
Leiomyosarcoma of the temporal boneOtol Neurotol, 32
S Tyanova (2016)
10.1038/ncomms10259Nat Commun, 7
J Barretina, G Caponigro, N Stransky, K Venkatesan, AA Margolin, S Kim, CJ Wilson, J Lehar, GV Kryukov, D Sonkin, A Reddy, M Liu, L Murray, MF Berger, JE Monahan, P Morais, J Meltzer, A Korejwa, J Jane-Valbuena, FA Mapa, J Thibault, E Bric-Furlong, P Raman, A Shipway, IH Engels, J Cheng, GK Yu, J Yu, P Aspesi, M Silva, K Jagtap, MD Jones, L Wang, C Hatton, E Palescandolo, S Gupta, S Mahan, C Sougnez, RC Onofrio, T Liefeld, L MacConaill, W Winckler, M Reich, N Li, JP Mesirov, SB Gabriel, G Getz, K Ardlie, V Chan, VE Myer, BL Weber, J Porter, M Warmuth, P Finan, JL Harris, M Meyerson, TR Golub, MP Morrissey, WR Sellers, R Schlegel, LA Garraway (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityNature, 483
O Berlin, L Angervall, LG Kindblom, IC Berlin, B Stener (1987)
Primary leiomyosarcoma of bone. A clinical, radiographic, pathologic-anatomic, and prognostic study of 16 casesSkelet Radiol, 16
WI Schaeffer (1984)
Usage of vertebrate, invertebrate and plant cell, tissue and organ culture terminologyIn Vitro, 20
E Altermann (2005)
10.1186/1471-2164-6-60BMC Genomics, 6
E Altermann, TR Klaenhammer (2005)
PathwayVoyager: pathway mapping using the Kyoto Encyclopedia of Genes and Genomes (KEGG) databaseBMC Genomics, 6
JA Ursick (2011)
10.1097/MAO.0b013e3181e9befeOtol Neurotol, 32
AT Pearson, KA Finkel, KA Warner, F Nor, D Tice, MD Martins, TL Jackson, JE Nor (2016)
Patient-derived xenograft (PDX) tumors increase growth rate with timeOncotarget, 7
SH Kresse, LA Meza-Zepeda, I Machado, A Llombart-Bosch, O Myklebost (2012)
Preclinical xenograft models of human sarcoma show nonrandom loss of aberrationsCancer, 118
M Ikram, I Ahmed, D Ahmed, YI Ahmed (2003)
Leiomyosarcoma of the maxilla with spinal metastasis: a case reportEar Nose Throat J, 82
J Barretina (2012)
10.1038/nature11003Nature, 483
CR Antonescu, RA Erlandson, AG Huvos (1997)
Primary leiomyosarcoma of bone: a clinicopathologic, immunohistochemical, and ultrastructural study of 33 patients and a literature reviewAm J Surg Pathol, 21
LC Carter (1999)
10.1016/S1079-2104(99)70248-9Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 87
T Kondo, S Hirohashi (2007)
Application of highly sensitive fluorescent dyes (CyDye DIGE Fluor saturation dyes) to laser microdissection and two-dimensional difference gel electrophoresis (2D-DIGE) for cancer proteomicsNat Protoc, 1
R Oyama (2017)
10.1038/s41598-017-04967-0Sci Rep, 7
AL Soderholm, C Lindqvist, L Teppo, J Wolf, J Sane (1988)
Bone resection in patients with mandibular sarcomaJ Cranio-maxillo-fac Surg, 16
B Rekhi (2011)
10.1016/j.anndiagpath.2010.11.006Ann Diagn Pathol, 15
P Brewer, V Sumathi, RJ Grimer, SR Carter, RM Tillman, A Abudu, L Jeys (2012)
Primary leiomyosarcoma of bone: analysis of prognosisSarcoma, 2012
WD Stein (2004)
10.1158/0008-5472.CAN-03-3383Cancer Res, 64
LC Carter, A Aguirre, B Boyd, MD DeLacure (1999)
Primary leiomyosarcoma of the mandible in a 7-year-old girl: report of a case and review of the literatureOral Surg Oral Med Oral Pathol Oral Radiol Endod, 87
K Izumi, T Maeda, J Cheng, T Saku (1995)
Primary leiomyosarcoma of the maxilla with regional lymph node metastasis. Report of a case and review of the literatureOral Surg Oral Med Oral Pathol Oral Radiol Endod, 80
R Oyama, M Takahashi, A Yoshida, M Sakumoto, Y Takai, F Kito, K Shiozawa, Z Qiao, Y Arai, T Shibata, Y Araki, M Endo, A Kawai, T Kondo (2017)
Generation of novel patient-derived CIC- DUX4 sarcoma xenografts and cell linesSci Rep, 7
M Sakumoto, M Takahashi, R Oyama, Y Takai, F Kito, K Shiozawa, Z Qiao, A Yoshida, M Endo, A Kawai, T Kondo (2017)
Establishment and proteomic characterization of NCC-LMS1-C1, a novel cell line of primary leiomyosarcoma in the boneJap J Clin Oncol, 47
WD Stein, T Litman, T Fojo, SE Bates (2004)
A Serial Analysis of Gene Expression (SAGE) database analysis of chemosensitivity: comparing solid tumors with cell lines and comparing solid tumors from different tissue originsCancer Res, 64
E Stewart, SM Federico, X Chen, AA Shelat, C Bradley, B Gordon, A Karlstrom, NR Twarog, MR Clay, A Bahrami, BB Freeman, B Xu, X Zhou, J Wu, V Honnell, M Ocarz, K Blankenship, J Dapper, ER Mardis, RK Wilson, J Downing, J Zhang, J Easton, A Pappo, MA Dyer (2017)
Orthotopic patient-derived xenografts of paediatric solid tumoursNature, 549
MM Tomayko, CP Reynolds (1989)
Determination of subcutaneous tumor size in athymic (nude) miceCancer Chemother Pharmacol, 24
JP Gillet (2011)
10.1073/pnas.1111840108Proc Natl Acad Sci U S A, 108
K Izumi (1995)
10.1016/S1079-2104(05)80389-0Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 80
T Goto (2002)
10.1007/s007760200045J Orthop Sci, 7
DF Quail, JA Joyce (2013)
Microenvironmental regulation of tumor progression and metastasisNat Med, 19
J Stebbing, K Paz, GK Schwartz, LH Wexler, R Maki, RE Pollock, R Morris, R Cohen, A Shankar, G Blackman, V Harding, D Vasquez, J Krell, S Zacharoulis, D Ciznadija, A Katz, D Sidransky (2014)
Patient-derived xenografts for individualized care in advanced sarcomaCancer, 120
MC Bouaziz (2005)
10.1097/01.rct.0000159581.54555.08J Comput Assist Tomogr, 29
E Stewart (2017)
10.1038/nature23647Nature, 549
P Brewer (2012)
10.1155/2012/636849Sarcoma, 2012
S Tyanova, R Albrechtsen, P Kronqvist, J Cox, M Mann, T Geiger (2016)
Proteomic maps of breast cancer subtypesNat Commun, 7
BG Kim (2013)
10.3342/ceo.2013.6.4.254Clin Exp Otorhinolaryngol, 6
A Ertel, A Verghese, SW Byers, M Ochs, A Tozeren (2006)
Pathway-specific differences between tumor cell lines and normal and tumor tissue cellsMol Cancer, 5
O Berlin (1987)
10.1007/BF00350962Skelet Radiol, 16
H Atalar (2008)
10.1016/j.clinimag.2007.10.022Clin Imaging, 32
CL Young, LE Wold, RA McLeod, FH Sim (1988)
Primary leiomyosarcoma of boneOrthopedics, 11
MA Adelani (2009)
10.5858/133.9.1448Arch Pathol Lab Med, 133
FE Vera-Badillo, M Al-Mubarak, AJ Templeton, E Amir (2013)
Benefit and harms of new anti-cancer drugsCurr Oncol Rep, 15
S Domcke, R Sinha, DA Levine, C Sander, N Schultz (2013)
Evaluating cell lines as tumour models by comparison of genomic profilesNat Commun, 4
JL Myers, J Arocho, W Bernreuter, W Dunham, MT Mazur (1991)
Leiomyosarcoma of bone. A clinicopathologic, immunohistochemical, and ultrastructural study of five casesCancer, 67
U Ben-David, G Ha, YY Tseng, NF Greenwald, C Oh, J Shih, JM McFarland, B Wong, JS Boehm, R Beroukhim, TR Golub (2017)
Patient-derived xenografts undergo mouse-specific tumor evolutionNat Genet, 49
M Hidalgo (2014)
10.1158/2159-8290.CD-14-0001Cancer Discov, 4
GS Karagiannis, T Poutahidis, SE Erdman, R Kirsch, RH Riddell, EP Diamandis (2012)
Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissueMol Cancer Res, 10
DF Quail (2013)
10.1038/nm.3394Nat Med, 19
JL Myers (1991)
10.1002/1097-0142(19910215)67:4<1051::AID-CNCR2820670431>3.0.CO;2-4Cancer, 67
A Ertel (2006)
10.1186/1476-4598-5-55Mol Cancer, 5
M Sakumoto (2017)
10.1093/jjco/hyx096Jap J Clin Oncol, 47
H Atalar, C Gunay, Y Yildiz, Y Saglik (2008)
Primary leiomyosarcoma of bone: a report on three patientsClin Imaging, 32
U Ben-David (2017)
10.1038/ng.3967Nat Genet, 49
SH Kresse (2012)
10.1002/cncr.26276Cancer, 118
CL Young (1988)
10.3928/0147-7447-19880401-13Orthopedics, 11
GS Karagiannis (2012)
10.1158/1541-7786.MCR-12-0307Mol Cancer Res, 10
S Hannachi Sassi, R Khattech, R Dhouib, S Rameh, K Mrad, M Douik, K Ben Romdhane (1999)
Primary bone leiomyosarcoma. Anatomo-clinical, immunohistochemical, and ultrastructural studyRev Chir Orthop Reparatrice Appar Mot, 85
AT Pearson (2016)
10.18632/oncotarget.6919Oncotarget, 7
M Hidalgo, F Amant, AV Biankin, E Budinska, AT Byrne, C Caldas, RB Clarke, S Jong, J Jonkers, GM Maelandsmo, S Roman-Roman, J Seoane, L Trusolino, A Villanueva (2014)
Patient-derived xenograft models: an emerging platform for translational cancer researchCancer Discov, 4
T Kondo (2007)
10.1038/nprot.2006.421Nat Protoc, 1
FE Vera-Badillo (2013)
10.1007/s11912-013-0303-yCurr Oncol Rep, 15
MC Bouaziz, S Chaabane, K Mrad, S Oueslati, A Bellassoued, MF Ladeb, KB Rhomdhane (2005)
Primary leiomyosarcoma of bone: report of 4 casesJ Comput Assist Tomogr, 29
T Goto, T Ishida, N Motoi, S Yokokura, H Kawano, A Yamamoto, K Matsuda, M Yamamoto (2002)
Primary leiomyosarcoma of the femurJ Orthop Sci, 7
JP Gillet, AM Calcagno, S Varma, M Marino, LJ Green, MI Vora, C Patel, JN Orina, TA Eliseeva, V Singal, R Padmanabhan, B Davidson, R Ganapathi, AK Sood, BR Rueda, SV Ambudkar, MM Gottesman (2011)
Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistanceProc Natl Acad Sci U S A, 108
DM Evans (1965)
10.1002/path.1700900145J Pathol Bacteriol, 90
WI Schaeffer (1984)
10.1007/BF02633327In Vitro, 20
JR Wisniewski (2009)
10.1038/nmeth.1322Nat Methods, 6
AL Soderholm (1988)
10.1016/S1010-5182(88)80051-9J Cranio-maxillo-fac Surg, 16
BG Kim, J Kim, WS Lee (2013)
Leiomyosarcoma of the middle ear and temporal boneClin Exp Otorhinolaryngol, 6
J Stebbing (2014)
10.1002/cncr.28696Cancer, 120
B Rekhi, A Kaur, A Puri, S Desai, NA Jambhekar (2011)
Primary leiomyosarcoma of bone—a clinicopathologic study of 8 uncommon cases with immunohistochemical analysis and clinical outcomesAnn Diagn Pathol, 15
Primary leiomyosarcoma (LMS) of bone is a rare and aggressive mesenchymal malignancy that differentiates toward smooth muscle. Complete resection is the only curable treatment, and novel therapeutic approaches for primary LMS of bone have long been desired. Patient-derived xenografts (PDXs) and cell lines are invaluable tools for preclinical studies. Here, we established PDXs from a patient with primary LMS of bone and a cell line from an established PDX. Bone primary LMS tissue was subcutaneously implanted into highly immune-deficient mice. After two passages, a piece of the tumor was subjected to tissue culturing, and a morphological evaluation and proteomic analysis were performed on the PDX and the established cell line. Moreover, the responses of the established cell line to anti-cancer drugs were examined. Microscopic observations revealed that the PDX tumors retained their original histology. The cell line was established from the third-generation PDX and named NCC-LMS1-X3-C1. The cells were maintained for over 18 mo and 40 passages. The cells exhibited a spindle shape and aggressive growth. Mass spectrometric protein identification revealed that the original tumor tissue, PDX tumor tissue, and NCC-LMS1-X3-C1 cells had similar but distinct protein expression profiles. We previously established the cell line, NCC-LMS1-C1, from the tumor tissue of same patient. We found that the response to drug treatments was different between NCC-LMS1-X3-C1 and NCC-LMS1-C1, suggesting the heterogeneous traits of tumor cells in the identical tumor tissue. This set of PDXs and stable cell line will be a useful resource for bone LMS research.
In Vitro Cellular & Developmental Biology - Animal – Springer Journals
Published: May 29, 2018
Access the full text.
Sign up today, get DeepDyve free for 14 days.